FDA Rejection Of Avastin For Breast Cancer Therapy Would Be ‘Unscientific, Unethical,’ Editorial Says

It would “not only be unscientific but unethical” for FDA to reject Genentech’s colon and lung cancer treatment Avastin for use as metastatic breast cancer treatment, a

More: continued here

Filed under: Breast Cancer on February 26th, 2008